Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05612373 · ClinicalTrials.gov registry record · NA
Message Offering Free Round Trip Ride-Share Ride to Pharmacy
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 300,000
- Enrollment target
NCT05612373: Completed NA study, sponsored by University of Pennsylvania.
NCT05612373 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 300,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05612373, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 300,000 participants
- Enrollment target
Study Summary
This experiment is part of a megastudy with a total of ten experimental conditions and a holdout control condition to which patients will be randomly assigned. The focal comparison in this experiment is between a message encouraging vaccination that provides patients with a free round trip ride-share ride to and from any pharmacy near them and a control message telling patients that an updated COVID booster vaccine is waiting for them.
Interventions
- BEHAVIORAL COVID Booster text messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300,000 participants |
| Start Date | 2022-11-03 |
| Est. Completion | 2023-02-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05612373
The ClinicalTrials.gov registry entry for NCT05612373 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which COVID Booster text messages is the first listed.
NCT05612373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05612373 about?
NCT05612373 is a clinical study titled "Message Offering Free Round Trip Ride-Share Ride to Pharmacy". This experiment is part of a megastudy with a total of ten experimental conditions and a holdout control condition to which patients will be randomly assigned. The focal comparison in this experiment is between a message encouraging vaccination that provides patients with a free round trip ride-shar...
What is the current status of trial NCT05612373?
This trial is currently completed. It is a NA study. The enrollment target is 300,000 participants. The study started on 2022-11-03. Estimated completion is 2023-02-06.
What interventions are being tested in trial NCT05612373?
The interventions under investigation include: COVID Booster text messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT05612373?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.